Cabaletta Bio (CABA) Free Cash Flow (2018 - 2025)
Cabaletta Bio's quarterly Free Cash Flow came in at -$34.3 million in Q4 2025, down 46.05% year-on-year from -$63.6 million in Q4 2024, and up 3.3% quarter-over-quarter from -$35.5 million in Q3 2025.
Cabaletta Bio has reported Free Cash Flow for 8 years, with the latest figure at -$34.3 million in Q4 2025.
- For the quarter ending Q4 2025, Free Cash Flow fell 46.05% year-over-year to -$34.3 million; the trailing twelve-month figure through Dec 2025 stood at -$131.1 million (down 44.95% YoY), and the FY2025 full-year result was -$131.1 million, down 44.95% from the prior year.
- Free Cash Flow for Q4 2025 stood at -$34.3 million, up from -$35.5 million in the prior quarter.
- The five-year high for Free Cash Flow was -$6.7 million in Q2 2021, with the low at -$35.5 million in Q3 2025.
- Average Free Cash Flow over 5 years is -$17.9 million, with a median of -$13.0 million recorded in 2022.
- Year-over-year, Free Cash Flow advanced 13.88% in 2022 and slumped 89.79% in 2024.
- Tracing CABA's Free Cash Flow over 5 years: stood at -$11.6 million in 2021, then advanced by 13.88% to -$10.0 million in 2022, then tumbled by 66.58% to -$16.6 million in 2023, then sank by 41.15% to -$23.5 million in 2024, then slumped by 46.05% to -$34.3 million in 2025.
- The last three Free Cash Flow figures came in at -$34.3 million (Q4 2025), -$35.5 million (Q3 2025), and -$30.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Cabaletta Bio | 194.84 Mn | 61.24 Mn | - | -34.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -34.32 Mn |
| Dec 31, 2025 | -34.32 Mn |
| Sep 30, 2025 | -35.49 Mn |
| Sep 30, 2025 | -35.49 Mn |
| Jun 30, 2025 | -30.47 Mn |
| Jun 30, 2025 | -30.47 Mn |
| Mar 31, 2025 | -30.80 Mn |
| Mar 31, 2025 | -30.80 Mn |
| Dec 31, 2024 | -23.50 Mn |
| Dec 31, 2024 | -23.50 Mn |
| Sep 30, 2024 | -21.78 Mn |
| Sep 30, 2024 | -21.78 Mn |
| Jun 30, 2024 | -20.50 Mn |
| Jun 30, 2024 | -20.50 Mn |
| Mar 31, 2024 | -24.65 Mn |
| Mar 31, 2024 | -24.65 Mn |
| Dec 31, 2023 | -16.65 Mn |
| Dec 31, 2023 | -16.65 Mn |
| Sep 30, 2023 | -12.67 Mn |
| Sep 30, 2023 | -12.67 Mn |
| Jun 30, 2023 | -11.95 Mn |
| Jun 30, 2023 | -11.95 Mn |
| Mar 31, 2023 | -12.99 Mn |
| Mar 31, 2023 | -12.99 Mn |
| Dec 31, 2022 | -9.99 Mn |
| Dec 31, 2022 | -9.99 Mn |
| Sep 30, 2022 | -11.64 Mn |
| Sep 30, 2022 | -11.64 Mn |
| Jun 30, 2022 | -11.80 Mn |
| Jun 30, 2022 | -11.80 Mn |
| Mar 31, 2022 | -12.96 Mn |
| Mar 31, 2022 | -12.96 Mn |
| Dec 31, 2021 | -11.61 Mn |
| Dec 31, 2021 | -11.61 Mn |
| Sep 30, 2021 | -7.94 Mn |
| Sep 30, 2021 | -7.94 Mn |
| Jun 30, 2021 | -6.69 Mn |
| Jun 30, 2021 | -6.69 Mn |
| Mar 31, 2021 | -9.05 Mn |
| Mar 31, 2021 | -9.05 Mn |
| Dec 31, 2020 | -9.40 Mn |
| Dec 31, 2020 | -9.40 Mn |
| Sep 30, 2020 | -5.19 Mn |
| Sep 30, 2020 | -5.19 Mn |
| Jun 30, 2020 | -7.66 Mn |
| Jun 30, 2020 | -7.66 Mn |
| Mar 31, 2020 | -5.16 Mn |
| Mar 31, 2020 | -5.16 Mn |
| Dec 31, 2019 | -7.94 Mn |
| Dec 31, 2019 | -7.94 Mn |
| Sep 30, 2019 | -1.87 Mn |
| Sep 30, 2019 | -1.87 Mn |
| Jun 30, 2019 | -4.02 Mn |
| Jun 30, 2019 | -4.02 Mn |
| Mar 31, 2019 | -2.45 Mn |
| Mar 31, 2019 | -2.45 Mn |
| Dec 31, 2018 | -1.91 Mn |
| Dec 31, 2018 | -1.91 Mn |